Jan 13, 2022 / 02:45PM GMT
Tessa Thomas Romero - JPMorgan Chase & Co, Research Division - Associate
Welcome, everyone, to the 40th Annual JPMorgan Healthcare conference. My name is Tessa Romero. I'm one of the senior biotechnology analyst here at JPMorgan. I'm joined by [Taylor Hanley] from the team. Our next presenting company is BioXcel Therapeutics. And presenting on behalf of the company, we have CEO, Vimal Mehta. Before I hand it over, I'd like to just remind all of our listeners to please use the "Ask a question" button in the portal to ask any of your question, and I'm happy to get it in on your behalf.
With that, I will hand it over to you.
Vimal D. Mehta - BioXcel Therapeutics, Inc. - Founder, CEO, President, & Director
Thank you, Tessa. Thank you to our host JPMorgan for the opportunity to present today. And good morning, all. We were eager to meet with you in person this year, but the unfortunate realities of the pandemic continue to force us into this virtual format. With that said, let's jump in and discuss the many exciting things that are happening at
BioXcel Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot